Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.64 |
| ▸ | NPY1R | P25929 | 11/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.64 |
| ▸ | NPY2R | P49146 | 7/20 | 0.64 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241711 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29947151 | 0.94 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29947137 | 0.94 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29531992 | 0.91 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL3138301 | 0.91 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30958046 | 0.91 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29794924 | 0.91 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL3138312 | 0.91 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL18758140 | 0.90 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RDPP7 | |
| SCHEMBL29947050 | 0.89 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230046772-A1 | CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX N.V. (BE) | 2023-02-16 | — | — | US | disclosed |
| EP-2765190-B1 | MUTANT Y-GLUTAMYLTRANSFERASE, AND METHOD FOR PRODUCING Y-GLUTAMYLVALYLGLYCINE OR SALT THEREOF | AJINOMOTO KK (JP) | 2018-05-23 | — | — | EP | disclosed |
| US-9677106-B2 | Method for producing gamma-glutamylvalylglycine or a salt thereof | AJINOMOTO CO., INC. (JP) | 2017-06-13 | — | — | US | disclosed |
| US-9580696-B2 | Method for producing γ-glutamylvalylglycine or a salt thereof | AJINOMOTO CO., INC. (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20160355861-A1 | METHOD FOR PRODUCING GAMMA-GLUTAMYLVALYLGLYCINE OR A SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2016-12-08 | — | — | US | disclosed |
| EP-2298909-B1 | Novel peptide-forming enzyme gene | AJINOMOTO KK (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2298908-B1 | Novel peptide-forming enzyme gene | AJINOMOTO KK (JP) | 2014-08-20 | — | — | EP | disclosed |
| EP-2298907-B1 | Novel peptide-forming enzyme gene | AJINOMOTO KK (JP) | 2014-08-20 | — | — | EP | disclosed |
| EP-2765190-A1 | MUTANT -GLUTAMYLTRANSFERASE, AND METHOD FOR PRODUCING -GLUTAMYLVALYLGLYCINE OR SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2014-08-13 | — | — | EP | disclosed |
| US-20140212920-A1 | MUTANT GAMMA-GLUTAMYLTRANSFERASE, AND A METHOD FOR PRODUCING GAMMA-GLUTAMYLVALYLGLYCINE OR A SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2014-07-31 | — | — | US | disclosed |
| WO-2005010196-A1 | METHOD FOR PRODUCING DIPEPTIDES | AJINOMOTO CO., INC. (JP) | 2005-02-03 | — | — | WO | disclosed |
| US-20050019864-A1 | Novel peptide-forming enzyme gene | AJINOMOTO CO., INC. (JP) | 2005-01-27 | — | — | US | disclosed |
| CN-1558947-A | Gene of peptide-producing enzyme, and process for producing dipeptide | ֮����ʽ���� | 2004-12-29 | — | — | CN | disclosed |
| US-20040253665-A1 | Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them | AJINOMOTO CO., INC. (JP) | 2004-12-16 | — | — | US | disclosed |
| US-20040219631-A1 | Method for producing tripeptides and/or peptides longer than tripeptides | AJINOMOTO CO., INC. (JP) | 2004-11-04 | — | — | US | disclosed |
| US-20040204577-A1 | Novel peptide-forming enzyme gene | AJINOMOTO CO., INC. (JP) | 2004-10-14 | — | — | US | disclosed |
| CN-1529712-A | Process for producing dipeptide, peptide-producing enzyme used therein, and process for producing peptide-producing enzyme | ֮����ʽ���� | 2004-09-15 | — | — | CN | disclosed |
| US-20040137558-A1 | Process for producing dipeptide, peptide synthase to be used therein and process for producing peptide synthase | AJINOMOTO CO., INC. (JP) | 2004-07-15 | — | — | US | disclosed |
| EP-1411062-A1 | PROCESS FOR PRODUCING DIPEPTIDE,PEPTIDE SYNTHASE TO BE USED THEREIN AND PROCESS FOR PRODUCING PEPTIDE SYNTHASE | Ajinomoto Co., Inc. (JP) | 2004-04-21 | — | — | EP | disclosed |
| EP-1411116-A1 | PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE | Ajinomoto Co., Inc. (JP) | 2004-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046772-A1 | CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | CX3CR1, CCR5, CXCR3 | NPY4R 1751/4885NPY1R 962/4885NPY5R 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.